Allianz SE Takes Position in The Cooper Companies, Inc. (NASDAQ:COO)

Allianz SE acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,400 shares of the medical device company’s stock, valued at approximately $128,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Byrne Asset Management LLC bought a new stake in shares of Cooper Companies during the fourth quarter worth $33,000. OFI Invest Asset Management acquired a new position in Cooper Companies in the 4th quarter worth $34,000. New Age Alpha Advisors LLC acquired a new position in Cooper Companies in the 4th quarter worth $38,000. West Financial Advisors LLC bought a new position in Cooper Companies during the 4th quarter worth about $49,000. Finally, Atala Financial Inc acquired a new stake in shares of Cooper Companies in the 4th quarter valued at about $51,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Price Performance

Shares of COO opened at $84.35 on Tuesday. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company’s fifty day simple moving average is $89.15 and its 200 day simple moving average is $97.03. The Cooper Companies, Inc. has a 1-year low of $77.05 and a 1-year high of $112.38. The company has a market cap of $16.87 billion, a price-to-earnings ratio of 43.26, a PEG ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. The company had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. On average, research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on COO. BNP Paribas raised Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. Stifel Nicolaus decreased their price target on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research note on Friday, March 7th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. Morgan Stanley reduced their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.